LipoScience will try again this week to take the company public, according to Reuters.

The wire service says LipoScience executives barnstormed across the country last week in an attempt to get investors to buy $75 million in stock. The offer was withdrawn by investment bankers at Merrill Lynch after failing to price the stock “as planned”.

The five percent drop in the Nasdaq helped stifle demand for LipoScience, Reuters says. But LipoScience execs are expected to resume their road show today.

LipoScience announced plans to go public in March.